Phase II Window Study of Olaparib Alone or with Cisplatin or Durvalumab in Operable Head and Neck CancerMyrto Moutafi, Amanda Psyrri, Georgia-Angeliki Koliou et al.|Cancer Research Communications|2023Cited by 19
Digital Spatial Profiling Links Beta-2-microglobulin Expression with Immune Checkpoint Blockade Outcomes in Head and Neck Squamous Cell CarcinomaNiki Gavrielatou, David L. Rimm, Ioannis Vathiotis et al.|Cancer Research Communications|2023Cited by 16
Quantitative immunofluorescence and mRNA analysis of immune-related biomarker groups in matched paired tumor samples from OPHELIA window study in head and neck squamous cell carcinoma (HNSCC).Amanda Psyrri, David L. Rimm, Myrto Moutafi et al.|Journal of Clinical Oncology|2021Cited by 2
Supplemental Figure 5 from Digital spatial profiling links beta-2-microglobulin expression with immune checkpoint blockade outcomes in head and neck squamous cell carcinomaNiki Gavrielatou, David L. Rimm, Ioannis Vathiotis et al.|Unknown|2023Cited by 0
Supplemental Figure 2 from Digital spatial profiling links beta-2-microglobulin expression with immune checkpoint blockade outcomes in head and neck squamous cell carcinomaNiki Gavrielatou, David L. Rimm, Ioannis Vathiotis et al.|Unknown|2023Cited by 0